IP Library › Granted Patent US 9,719,961
Granted Patent B2
US 9,719,961 · App. 15/183,097 · Granted Aug 1, 2017

Multichannel preparative electrophoresis system

Inventors: Douglas Grosvenor Sabin (Marblehead, MA); Todd J. Barbera (Marblehead, MA); Paul Chandler Sabin (Needham, MA); T. Christian Boles (Bedford, MA)
Assignee: SAGE SCIENCE, INC.
G01N27/44756G01N27/44791
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,719,961
App. No.
15/183,097
Granted
Aug 1, 2017
Kind
B2
Abstract

The invention provides an electrophoresis cassette, methods for making the electrophoresis cassette, and method of fractionating analytes from a sample based upon electrophoretic mobility in a single application of the sample to an electrophoretic system.

Claims (39)

1. A method of fractionating analytes within a sample contained within an electrophoresis cassette, comprising:

applying a voltage across an electrophoresis cassette, the cassette comprising:

a plate including at least one macrofluidic separation channel, the at least one macrofluidic channel having a first physically and electrically isolated portion, a second physically and electrically isolated portion, and a gel matrix;

a constriction point provided between the at least one macrofluidic separation channel and at least one of the first and second physically and electrically isolated portions;

an elution chamber positioned on one or another of the first and second physically and electrically isolated portions, the elution chamber comprising at least one of an elution cavity and an analyte-impermeable barrier; and

a sample well configured with a sample;

activating a positive electrode arranged proximate at least one of the first and second physically and electrically isolated portions upon at least one analyte having at least one desired property traversing the constriction point.

2. The method of claim 1 , further comprising:

detecting the at least one analyte having the at least one desired property traversing the constriction point, wherein upon detection, the positive electrode is activated.

3. The method of claim 1 , further comprising collecting the at least one analyte having the at least one desired property in the elution chamber.

4. The method of claim 1 , wherein the at least one desired property is selected from the group consisting of a molecular weight, a molecular mobility, and an optical property.

5. The method of claim 4 , wherein the molecular weight corresponds to a molecular weight marker within the sample.

6. The method of claim 1 , wherein the at least one desired property is selected from the group consisting of a desired molecular weight, a desired molecular mobility, and a desired optical property.

7. The method of claim 1 , wherein the method further comprises providing a detection system comprising:

a detector configured to detect the at least one analyte having the at least one desired property; and

a processor configured to selectively activate the positive electrode upon detection that the at least one analyte having the at least one desired property is traversing the constriction point.

8. The method of claim 7 , wherein:

the processor is programmable for selecting the at least one desired property, and

the processor is configured to activate the positive electrode upon detection that the at least one analyte having the programmed property is traversing the constriction point.

9. The method of claim 8 , wherein the at least one desired property comprises a specific or range of analyte molecular weight(s) and/or mobility(ies), and wherein the processor is configured to activate the positive electrode upon detecting that the at least one analyte having the specific/range molecular weight/mobility is traversing the constriction point.

10. The method of claim 1 , wherein the sample comprises a fluorescent compound and the analyte forms a complex with the fluorescent compound.

11. The method of claim 10 , wherein the fluorescent compound is a fluorophore.

12. The system of claim 1 , wherein the sample comprises a light-absorbing compound and the analyte forms a complex with the light-absorbing compound.

13. The system of claim 12 , wherein the light-absorbing compound is a chromophore.

14. The method of claim 4 , wherein the optical property is the emission of light or the absorption of light.

15. The method of claim 7 , wherein the processor receives a signal from the detector and applies an algorithm to determine the molecular weight of the at least one of an analyte.

16. The method of claim 1 , wherein the sample comprises at detectable compound, and/or the gel matrix composition includes at least one of a fluorophore that complexes to at least one of an analyte.

17. The method of claim 1 , wherein at least one of a buffer composition and an elution buffer is provided, and wherein at least one of the buffer composition and the elution buffer composition comprises at least one of a fluorophore and chromophore that complexes to the at least one analyte.

18. The method of claim 1 , wherein:

the plate includes at least two macrofluidic separation channels, each channel having a first physically and electrically isolated portion, a second physically and electrically isolated portion, and a gel matrix;

each channel is associated with:

a constriction point provided between a respective separation channel and at least one of the first and second physically and electrically isolated portions;

an elution chamber positioned on one or another of the first and second physically and electrically isolated portions, the elution chamber comprising at least one of an elution cavity and an analyte-impermeable barrier;

a sample well configured with a sample; and

at least one positive electrode arranged proximate at least one of the physically and electrically isolated portions associated with each channel;

and

each positive electrode is respectively activated upon at least one analyte having at least one desired property traversing the constriction point.

19. The method of claim 1 , wherein the analyte is a polynucleic acid or a polypeptide.

20. The method of claim 19 , wherein the polynucleic acid comprises deoxyribonucleic acid (DNA) or ribonucleic acid (RNA), the polynucleic acid is double or single stranded, and/or the polypeptide is native or denatured.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 18, 2017
From: SABIN, DOUGLAS GROSVENOR; BARBERA, TODD J.; SABIN, PAUL CHANDLER; BOLES, T. CHRISTIAN
To: SAGE SCIENCE, INC.
Reel/Frame 041008/0161 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 21, 2016
From: SABIN, DOUGLAS GROSVENOR; BARBERA, TODD J.; SABIN, PAUL CHANDLER; BOLES, T. CHRISTIAN
To: SAGE SCIENCE, INC.
Reel/Frame 041113/0652 →
Continuity (7)
Continuation 14297001 · Jun 5, 2014
Continuation 13751606 · Jan 28, 2013
Continuation 12760548 · Apr 14, 2010
Continuation In Part 12576148 · Oct 8, 2009
Provisional Application 61195566 · Oct 8, 2008
Provisional Application 61150243 · Feb 5, 2009
Related Publication 20160370318A1 · Dec 22, 2016